(lp0
S'CorMedix Inc. Reports Fourth Quarter and Full Year 2016 Financial Results and ... Yahoo Finance - Mar 17, 2017 BEDMINSTER, NJ / ACCESSWIRE / March 17, 2017 / CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory&nbsp;...CORMEDIX INC.  Files An 8-K Results of Operations and Financial ... - Market ExclusiveCorMedix crushed after warning on cash - Seeking Alpha'
p1
aS"BRIEF-Cormedix Inc full year 2016 loss per share $0.65 Reuters - Mar 17, 2017 Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news&nbsp;..."
p2
aS'Traders Take Note: CorMedix Inc  Stock Drops, Weakness in Technical ... CML News - 17 hours ago Take Note: CorMedix Inc  has hit some technical weakness in its momentum, and while it has not broken down all the way through support -- watch the key levels that we discuss below and further, watch the stochastics and technical oscillators&nbsp;...'
p3
aS'CorMedix Inc. CRMD  Wall Street Journal - Feb 11, 2011 News CorMedix Inc.CRMD. Significant News Only. 03/02/17; Press Release.  CorMedix Inc. Appoints John L.  Armstrong to Senior Leadership Team.'
p4
aS'CorMedix, Inc.  Recent Ownership Changes Post Analyst - 20 hours ago CorMedix, Inc.  reached 18.52% versus a 1-year low price of $1.35. The stock was last seen -9.09% lower, reaching at $1.6 on Mar. 21, 2017.Is There Any Upside to This Stock Under $5: CorMedix, Inc.  - Morgan Research'
p5
aS'CorMedix Inc. : Strong Sell On Partner Failure, -91.4% Downside: Pump ... ValueWalk - Jun 29, 2015 I believe CorMedix is one of the most brazen, worthless biotech shells of insider enrichment I have ever seen. Bankruptcy documents show Cormedix  is based on a 1970s-era catheter product acquired for &lt;$1m cash the last time this&nbsp;...CorMedix: Strong Sell On Partner Failure, Misleading Data And Paid Stock ... - Seeking Alpha'
p6
aS"Earnings Buzzers: CorMedix Inc.  Post Registrar - Mar 20, 2017 Shares of CorMedix Inc.  fell -13.04% to reach at $1.80 during previous trading session. The company has experienced volume of 1.60M shares while on average the company has a capacity of trading 186.96K share.CorMedix, Inc. : Important Trade and Target Levels To Watch - Post AnalystCorMedix, Inc.'s  stock price is now worth at $1.80 while Analyst mean ... - Hot Stocks Point"
p7
aS'CorMedix Inc. Receives Positive Feedback from FDA for Neutrolin Clinical ... PR Newswire  - Jun 17, 2015 BEDMINSTER, N.J., June 17, 2015 /PRNewswire/ -- CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease,&nbsp;...CorMedix  Stock Gains After Receiving Positive FDA Feedback for Neutrolin - TheStreet.com'
p8
aS'What Happened to CorMedix Inc.  MicroCap Daily - Jul 29, 2015 CorMedix Inc.  recently saw a parabolic rise to highs of $10.40 a share off its base at just over $1. Since then the stock has been in steep decline heading back to where it started.'
p9
aS'Resonant Down 70% Could CorMedix Inc.  Be Next? ValueWalk - Apr 13, 2015 CorMedix has a market capitalization of $400 million, its stock is up 370% year to date, its trading at 2,000x 2014 revenue , it has a going concern, it needs to raise capital, it recently filed an equity offering, it faces significant ...'
p10
a.